secwatch.observer — SEC 8-K summary
======================================

Issuer:     Valion Bio, Inc. (VBIO)
CIK:        0001787740
Form:       8-K
Filed at:   2024-07-03T23:59:59+00:00
Accession:  0000950170-24-081608
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Tivic Health receives Nasdaq delisting notice for bid price below $1.00 for 33 days
--------------------------------------------------------------------------------

- Received Nasdaq deficiency letter on June 28, 2024 for non-compliance with minimum bid price requirement.
- Closing bid price below $1.00 per share for 33 consecutive business days.
- 180-day cure period ends December 26, 2024; must close at or above $1.00 for 10 consecutive days.
- If not compliant by deadline, may request a second 180-day period if other listing standards are met.
- Listing remains fully effective during cure period; company evaluating options to regain compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1787740/000095017024081608/0000950170-24-081608-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1787740/000095017024081608/tivc-20240628.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-081608

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer